Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NOBELREPLACE Tapered Groovy RP 4.3x16mm: medical device reports filed with FDA

1,466 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,466
device reports naming the brand
0% of all MAUDE reports · about 215 a year
134
reports, 12 months to August 2026
114 in the 12 months before
0.3%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,466 reports that name the brand "NOBELREPLACE Tapered Groovy RP 4.3x16mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

134 reports arrived in the 12 months to August 2026, up 18% from 114 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.7%) and malfunction (0.3%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are loss of osseointegration (62.1%), failure to osseointegrate (29.2%) and osseointegration problem (5%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02651Sep 2021: 24Oct 2021: 14Nov 2021: 14Dec 2021: 262022Jan 2022: 8Feb 2022: 18Mar 2022: 16Apr 2022: 16May 2022: 18Jun 2022: 18Jul 2022: 8Aug 2022: 18Sep 2022: 19Oct 2022: 51Nov 2022: 10Dec 2022: 282023Jan 2023: 12Feb 2023: 22Mar 2023: 26Apr 2023: 10May 2023: 2Jun 2023: 20Jul 2023: 8Aug 2023: 10Sep 2023: 4Oct 2023: 26Nov 2023: 6Dec 2023: 182024Jan 2024: 27Feb 2024: 26Mar 2024: 24Apr 2024: 2May 2024: 18Jun 2024: 38Jul 2024: 10Aug 2024: 18Sep 2024: 14Oct 2024: 13Nov 2024: 1Dec 2024: 202025Jan 2025: 12Feb 2025: 6Mar 2025: 14Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 24Aug 2025: 10Sep 2025: 4Oct 2025: 10Nov 2025: 6Dec 2025: 82026Jan 2026: 8Feb 2026: 10Mar 2026: 12Apr 2026: 28May 2026: 6Jun 2026: 20Jul 2026: 12Aug 2026: 10

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01633262019: 13220192020: 20520202021: 32620212022: 22820222023: 16420232024: 21120242025: 9420252026: 1062026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.7%1,461
Malfunction0.3%5
Other0%0
Not given0%0

Who filed the report

Manufacturer report53.9%790
Voluntary report0%0
User facility report0%0
Distributor report46.1%676
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Loss of osseointegration91062.1%22.4%
Failure to osseointegrate42829.2%62.8%
Osseointegration problem745%7.7%
Fracturea broken bone312.1%1.6%
Insufficient device problem information60.4%0.2%
Migrationthe device moved from where it was placed40.3%0.1%
Corrodedthe device corroded20.1%0%
Difficult to removethe device was hard to remove20.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,28887.9%
Painpain, site not specified18512.6%
Numbnessnumbness382.6%
Appropriate clinical signs, symptoms and conditions term/code not available161.1%
Abscessa collection of pus60.4%
Fistula60.4%
Foreign body in patientpart of a device left in the patient40.3%
Inflammationinflammation40.3%
Bone fracture(s)20.1%
Osteomyelitis20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNOBELREPLACE Tapered Groovy RP 4.3x16mmProduct code DZEAll MAUDE reports
Reports1,4663,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury99.7%99.2%36.2%
Classified as malfunction0.3%0.8%62.3%
Filed by the manufacturer53.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NOBELREPLACE Tapered Groovy RP 4.3x16mm reports

How many FDA reports name NOBELREPLACE Tapered Groovy RP 4.3x16mm?

1,466 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 134 in the latest 12 months.

What kinds of events are reported?

injury (99.7%) and malfunction (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

loss of osseointegration (62.1%), failure to osseointegrate (29.2%), osseointegration problem (5%), fracture (2.1%) and insufficient device problem information (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (53.9%) and distributor reports (46.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NOBELREPLACE Tapered Groovy RP 4.3x16mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.